a Drug Delivery Research Group, Faculty of Health and Environmental Sciences, Auckland University of Technology , Auckland , New Zealand.
b Health and Community and Animal and Environmental Sciences Network , Unitec Institute of Technology, Mount Albert , Auckland , New Zealand.
Pharm Dev Technol. 2019 Sep;24(7):839-848. doi: 10.1080/10837450.2019.1602632. Epub 2019 May 14.
This study investigated a chemically crosslinked poly(vinyl alcohol) (PVA) hydrogel controlled drug delivery system to deliver the anti-inflammatory drug dexamethasone (DEX). The PVA hydrogels, with different crosslinking densities, were characterized by swelling studies, electron scanning microscopy, viscosity, Fourier transform infrared spectroscopy (FTIR) and in vitro release assessment. Increasing crosslinking density slowed and decreased swelling and water absorption. FTIR analysis suggested DEX has possible interactions with the crosslinker and the PVA polymer. In vitro release of DEX from PVA hydrogels was sustained for 33 days and appeared to fit the Higuchi and Korsmeyer-Peppas models. This work indicates the likelihood of PVA hydrogel as a controlled drug release system for DEX for anti-inflammatory uses.
本研究探讨了一种化学交联的聚乙烯醇(PVA)水凝胶控释给药系统,以递送抗炎药物地塞米松(DEX)。通过溶胀研究、电子扫描显微镜、粘度、傅里叶变换红外光谱(FTIR)和体外释放评估,对具有不同交联密度的 PVA 水凝胶进行了表征。交联密度的增加减缓并降低了溶胀和吸水率。FTIR 分析表明 DEX 可能与交联剂和 PVA 聚合物相互作用。DEX 从 PVA 水凝胶中的体外释放持续了 33 天,似乎符合 Higuchi 和 Korsmeyer-Peppas 模型。这项工作表明 PVA 水凝胶作为 DEX 的抗炎用途的控释给药系统的可能性。